Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients.

Saeed MJ, Olsen MA, Powderly WG, Presti RM.

J Clin Gastroenterol. 2017 Jan;51(1):70-76.

PMID:
27306942
2.

Update on hepatitis B and C virus diagnosis.

Villar LM, Cruz HM, Barbosa JR, Bezerra CS, Portilho MM, Scalioni Lde P.

World J Virol. 2015 Nov 12;4(4):323-42. doi: 10.5501/wjv.v4.i4.323. Review.

3.

Era of direct acting antivirals in chronic hepatitis C: Who will benefit?

Fung J.

World J Hepatol. 2015 Oct 28;7(24):2543-50. doi: 10.4254/wjh.v7.i24.2543. Review.

4.

A B C d e f g ...

Shafran S, Conly J.

Can J Infect Dis. 1996 May;7(3):181-2. No abstract available.

5.

Hepatitis C: Recent advances.

Shafran SD, Conly JM.

Can J Infect Dis. 1993 Jul;4(4):195-7. No abstract available.

6.

Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.

Liu L, Fisher BE, Thomas DL, Cox AL, Ray SC.

Hepatology. 2012 Jun;55(6):1684-91. doi: 10.1002/hep.25575. Epub 2012 Apr 18.

7.

Rapid multiplexed immunoassay for simultaneous serodiagnosis of HIV-1 and coinfections.

Lochhead MJ, Todorof K, Delaney M, Ives JT, Greef C, Moll K, Rowley K, Vogel K, Myatt C, Zhang XQ, Logan C, Benson C, Reed S, Schooley RT.

J Clin Microbiol. 2011 Oct;49(10):3584-90. doi: 10.1128/JCM.00970-11. Epub 2011 Aug 24.

8.

Novel evolved immunoglobulin (Ig)-binding molecules enhance the detection of IgM against hepatitis C virus.

Cao J, Chen Q, Zhang H, Qi P, Liu C, Yang X, Wang N, Qian B, Wang J, Jiang S, Yang H, Sun S, Pan W.

PLoS One. 2011 Apr 14;6(4):e18477. doi: 10.1371/journal.pone.0018477.

9.

Hepatocellular carcinoma in thalassemia: A critical review.

Mancuso A.

World J Hepatol. 2010 May 27;2(5):171-4. doi: 10.4254/wjh.v2.i5.171.

10.

Determination of risk factors for hepatitis B and C in male patients suffering from chronic hepatitis.

Qureshi H, Arif A, Riaz K, Alam SE, Ahmed W, Mujeeb SA.

BMC Res Notes. 2009 Oct 23;2:212. doi: 10.1186/1756-0500-2-212.

11.

The history of the "natural history" of hepatitis C (1968-2009).

Seeff LB.

Liver Int. 2009 Jan;29 Suppl 1:89-99. doi: 10.1111/j.1478-3231.2008.01927.x. Review.

12.

Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection.

Kim S, Kim JH, Yoon S, Park YH, Kim HS.

J Clin Microbiol. 2008 Dec;46(12):3919-23. doi: 10.1128/JCM.01603-08. Epub 2008 Oct 22.

13.

Prevalence of Hepatitis C virus antibody in patients with sexually transmitted diseases attending a Harrisburg, PA, STD clinic.

Sautter RL, Jones S, Weber DI, Lebar WD, Heitjan DF, Kopreski MM, Curcio FD.

Infect Dis Obstet Gynecol. 1994;1(6):269-74.

14.
15.

Hepatitis C: a review for primary care physicians.

Wong T, Lee SS.

CMAJ. 2006 Feb 28;174(5):649-59. Review. Erratum in: CMAJ. 2006 May 9;174(10):1450.

16.

Safety of the blood supply in Latin America.

Schmunis GA, Cruz JR.

Clin Microbiol Rev. 2005 Jan;18(1):12-29. Review. Erratum in: Clin Microbiol Rev. 2005 Jul;18(3):582.

17.

Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation.

Yoshida T, Hanada T, Tokuhisa T, Kosai K, Sata M, Kohara M, Yoshimura A.

J Exp Med. 2002 Sep 2;196(5):641-53.

19.
20.

Antigenic heterogeneity of the hepatitis C virus NS5A protein.

Dou XG, Talekar G, Chang J, Dai X, Li L, Bonafonte MT, Holloway B, Fields HA, Khudyakov YE.

J Clin Microbiol. 2002 Jan;40(1):61-7.

Supplemental Content

Support Center